Erdafitinib Alternatives Compared
| Erdafitinib | Cisplatin | Mitomycin |
|
|---|
| Erdafitinib | Cisplatin | Mitomycin |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Urothelial Carcinoma, Bladder Cancer. Erdafitinib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Bladder Cancer, Bone Marrow Transplantation, Anal Cancer, Blood Cell Transplantation, Brain Tumor, Cervical Cancer, Nasopharyngeal Carcinoma, Neuroblastoma, Non Small Cell Lung Cancer... View more |
Prescription only
Prescribed for Bladder Cancer, Anal Cancer, Urothelial Carcinoma, Pancreatic Cancer, Stomach Cancer. Mitomycin may also be used for purposes not listed in this medication guide. |
Related suggestions Bladder Cancer
|
|||||||||||||||
| More about Erdafitinib | More about Cisplatin | More about Mitomycin | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Erdafitinib has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Cisplatin has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Cisplatin prices |
View all Mitomycin prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Balversa |
N/A |
Jelmyto, Mutamycin | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
59 hours |
73 hours |
2 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 240 drugs are known to interact with Erdafitinib:
|
A total of 455 drugs are known to interact with Cisplatin:
|
A total of 259 drugs are known to interact with Mitomycin:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
April 12, 2019 |
December 19, 1978 |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.